Institutional investors hold a majority ownership of TEVA through the 58.60% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended March 2017, these large investors purchased a net $15.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 22.7 Million shares of Teva Pharmaceutical
NORTHERN CROSS LLC Bought 15.6 Million shares of Teva Pharmaceutical
CAPITAL RESEARCH & MANAGEMENT CO... Bought 7.8 Million shares of Teva Pharmaceutical